SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

XPHY (XPHY) News

Follow XPHY (XPHY) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol XPHY Asset market Sector Markets 90 days 0 Updated Jul 06, 2026, 07:05 AM UTC Open live news feed
L BioNxt Advances GLP-1 Sublingual Semaglutide ODF Program with Next Stage of Delivery Development Underway VANCOUVER, BC / / July 6, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:B EQUITY | Jul 06, 2026, 07:05 AM UTC